CYCC Bio Green Med Solution Inc.


$ 1.31 $ -0.02 (-1.14 %)    

Monday, 17-Nov-2025 12:07:12 EST
QQQ $ 609.78 $ 3.63 (0.6 %)
DIA $ 471.57 $ 0.67 (0.16 %)
SPY $ 672.07 $ 2.34 (0.36 %)
TLT $ 89.17 $ 0.09 (0.1 %)
GLD $ 375.38 $ 1.27 (0.34 %)
$ 1.31
$ 1.32
$ 1.29 x 825
$ 1.33 x 100
$ 1.31 - $ 1.31
$ 1.26 - $ 101.30
45,719
na
na
$ 1.29
na
TBD
na
na (na)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 cyclacel-pharmaceuticals-exchanges-series-c-warrants-for-559395-common-shares-in-agreement-with-accredited-investors

On September 4, 2025, Cyclacel Pharmaceuticals, Inc. (the "Company") entered into a Warrant Exchange Agreement (the ...

 cyclacel-pharmaceuticals-stock-up-346-in-massive-after-hours-rally

After sharing encouraging preclinical results for a potential biliary tract cancer treatment, Cyclacel Pharmaceuticals jumped 3...

 reported-earlier-cyclacel-announces-new-findings-supporting-use-of-plogosertib-in-biliary-tract-cancer-patients-with-high-bubr1-expression

  Biliary tract cancer (BTC) or cholangiocarcinoma is an aggressive tumor with poor prognosis 

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION